Search Results

71 - 80 of 661
Staff
Dr. Carolyn M. Hutter was the director of the Division of Genome Sciences at the National Human Genome Research Institute.​
… NIH in 2012, serving as a program director in the National Cancer Institute (NCI) Epidemiology and Genomics Research … a program director, serving as the NHGRI team lead for The Cancer Genome Atlas (TCGA) . Prior to NIH, she was a senior staff scientist at the Fred Hutchinson Cancer Research Center and lecturer at the University of …
Educational Resources
A retrovirus is a virus that uses RNA as its genetic material.
… material. … Acquired Immunodeficiency Syndrome (AIDS), Cancer, Cell, Deoxyribonucleic Acid (DNA), Genome, … associated with diseases, including AIDS and some forms of cancer. … A retrovirus is a virus that uses RNA as its …
News Release
NHGRI appointed Carolyn Hutter, Ph.D., director of the Division of Genome Sciences, which researches human genome function in health and disease.
… research programs. Most recently, she co-managed The Cancer Genome Atlas (TCGA) - a collaboration between NHGRI and the National Cancer Institute (NCI) - which generated over 2.5 petabytes of publically available genomic data used by the cancer research community to improve the prevention, …
Outreach
15 examples of how genomics has and continues to transform our world in myriad ways.
… Complete Genome Sequence, Genomics Impact On Society, Cancer Genomics, Genomic Testing, Enhanced Forensics, Genome …
Research at NHGRI
Families Sharing Health Assessment and Risk Evaluation (SHARE) helps you and your family learn how your family health history affects your risk for diseases.
… Colorectal Cancer Breast Cancer Prostate Cancer Type 2 Diabetes Heart … guidelines to reduce risk of heart disease, diabetes, breast cancer, and colorectal cancer .  BMC Public Health,   …
Clinical Research
The CLINSEQ® Study seeks to learn about the role that your genes play in your health.
… to a variety of conditions, including heart disease, breast cancer, and hearing loss. … Our goal is to enroll 1500 … Preliminary validation of a consumer-oriented colorectal cancer risk assessment tool compatible with the US Surgeon …
Fact Sheet
Pharmacogenomics is a growing area of genomic medicine that uses a person’s genomic information to help healthcare providers select the medications and dosages that are predicted to work best in each patient.
… testing can be used to determine if the tumor cells in a cancer patient have a specific version of a receptor, which … the choice of treatment. For example, some patients have breast cancers containing a receptor called HER2, which is called HER2-positive breast cancer.   HER2 receptors can cause the cancer to grow …
Event
On April 25, 2024, National DNA Day, the National Institutes of Health (NIH) will welcome a new statue, “The Ladder,” celebrating DNA and children.
… painting, sculpting, photography and writing.  Body image, cancer, genetics and our fragile democracy are her … her first social art project “Mamorial,” a nonprofit breast cancer initiative offering healing and awareness through art. …
News Release
The Genomics and Society: Expanding the ELSI Universe conference focused on issues arising from the ethical, legal and social implications of genomic research.
… to the genetic testing of women with family histories of breast cancer, genomics is rapidly becoming a fixture in our lives. …
Events
test
… MIT and Harvard, will present the lecture, Perspectives on Cancer Precision Medicine . Dr. Golub is a world leader in using genomics tools to understand the basis of cancer. He also pioneered the development of new cell-based approaches to drug discovery for cancer and other diseases. Golub is also the Charles A. Dana …